Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Margaret H Collins"'
Autor:
Sayantani B. Sindher, Suzanne Barshow, Jyothi Tirumalasetty, Stefania Arasi, Dan Atkins, Maureen Bauer, Philippe Bégin, Margaret H. Collins, Antoine Deschildre, Alfred D. Doyle, Alessandro Fiocchi, Glenn T. Furuta, Maria Garcia-Lloret, Maurizio Mennini, Marc E. Rothenberg, Jonathan M. Spergel, Julie Wang, Robert A. Wood, Benjamin L. Wright, Torsten Zuberbier, Andrew R. Chin, Andrew Long, Kari C. Nadeau, R. Sharon Chinthrajah
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:595-606
Autor:
Netali Ben-Baruch Morgenstern, Tetsuo Shoda, Yrina Rochman, Julie M. Caldwell, Margaret H. Collins, Vincent Mukkada, Philip E. Putnam, Scott M. Bolton, Jennifer M. Felton, Mark Rochman, Cristin Murray-Petzold, Kara L. Kliewer, Marc E. Rothenberg
Publikováno v:
Journal of Allergy and Clinical Immunology.
Autor:
Thomas Greuter, Alex Straumann, Yuniel Fernandez‐Marrero, Nina Germic, Aref Hosseini, Shida Yousefi, Dagmar Simon, Margaret H. Collins, Christian Bussmann, Mirna Chehade, Evan S. Dellon, Glenn T. Furuta, Nirmala Gonsalves, Ikuo Hirano, Fouad J. Moawad, Luc Biedermann, Ekaterina Safroneeva, Alain M. Schoepfer, Hans‐Uwe Simon
Publikováno v:
Greuter, Thomas; Straumann, Alex; Fernandez-Marrero, Yuniel; Germic, Nina; Hosseini, Aref; Yousefi, Shida; Simon, Dagmar; Collins, Margaret H; Bussmann, Christian; Chehade, Mirna; Dellon, Evan S; Furuta, Glenn T; Gonsalves, Nirmala; Hirano, Ikuo; Moawad, Fouad J; Biedermann, Luc; Safroneeva, Ekaterina; Schoepfer, Alain M; Simon, Hans-Uwe (2022). Characterization of eosinophilic esophagitis variants by clinical, histological and molecular analyses: A cross-sectional multi-center study. Allergy, 77(8), pp. 2520-2533. Wiley 10.1111/all.15233
OBJECTIVE Physicians are increasingly confronted with patients presenting with symptoms of esophageal dysfunction resembling eosinophilic esophagitis (EoE), but absence of significant esophageal eosinophilia. The purpose of this study was to characte
Autor:
Evan S, Dellon, Paneez, Khoury, Amanda B, Muir, Chris A, Liacouras, Ekaterina, Safroneeva, Dan, Atkins, Margaret H, Collins, Nirmala, Gonsalves, Gary W, Falk, Jonathan M, Spergel, Ikuo, Hirano, Mirna, Chehade, Alain M, Schoepfer, Calies, Menard-Katcher, David A, Katzka, Peter A, Bonis, Albert J, Bredenoord, Bob, Geng, Elizabeth T, Jensen, Robert D, Pesek, Paul, Feuerstadt, Sandeep K, Gupta, Alfredo J, Lucendo, Robert M, Genta, Girish, Hiremath, Emily C, McGowan, Fouad J, Moawad, Kathryn A, Peterson, Marc E, Rothenberg, Alex, Straumann, Glenn T, Furuta, Seema S, Aceves
Publikováno v:
J Allergy Clin Immunol
BACKGROUND & AIMS Disease activity and severity of eosinophilic esophagitis (EoE) dictate therapeutic options and management, but the decision-making process for determining severity varies among practitioners. To reduce variability in practice patte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109badf6bda27e0269585b1c7ea9cd04
Autor:
Philip E. Putnam, Glenn T. Furuta, Tetsuo Shoda, Rachel Sheridan, Nicoleta C. Arva, Julie M. Caldwell, Ikuo Hirano, J. Pablo Abonia, Seema S. Aceves, Nirmala Gonsalves, Margaret H. Collins, Ting Wen, Gary W. Falk, Garrett A. Osswald, Marc E. Rothenberg, Sandeep K. Gupta, Evan S. Dellon, Kelley E. Capocelli, Jonathan M. Spergel, Guang Yu Yang, Vincent A. Mukkada, John A. Besse, Dan Atkins, Amanda K. Rudman Spergel, Joshua B. Wechsler
Publikováno v:
J Allergy Clin Immunol
BACKGROUND: Eosinophilic gastritis (EG) is a clinicopathologic disorder with marked gastric eosinophilia and clinical symptoms. There is an unmet need in EG for more precise diagnostic tools. OBJECTIVE: We aimed to develop tissue- and blood-based dia
Autor:
Seema Aceves, Margaret H. Collins, Marc E. Rothenberg, Glenn T. Furuta, Nirmala Gonsalves, J. Pablo Abonia, Samuel Almonte, Rachel Andrews, Ashley Arrington, Nicoleta Arva, Fred Atkins, Dominique Bailey, Alexis Berry, Bridget Besl, Scott Bolton, Peter Bonis, Wendy Book, Kimberly Bray, Teresa Brown, Cassandra Burger, Deirdre Burke, Jonathon Cahoon, Kelley Capocelli, Mirna Chehade, Margaret Collins, Carla Davis, Evan Dellon, Maureen DeMarshall, Lauren DiTommaso, Ranjan Dohil, Michael Eby, Gary Falk, David Fleischer, Heather Foote, Kelci Foss, Joel Friedlander, Patricia Fulkerson, Glenn Furuta, Debra Geno, Thomas Greuter, Sandeep Gupta, Frank Hamilton, Kirk Harris, Jennifer Harris, Ikuo Hirano, Girish Hiremath, Nicole Holland-Thomas, Lea Jacinto, Amir Kagalwalla, Timothy Kaseta, David Katzka, Kaitlin Keeley, Emad Khosh-Hemmat, Paneez Khoury, Eileen King, Kara Kliewer, Amy Klion, Jennifer Knowles, Kendra Kocher, Ellyn Kodroff, Jeffrey Krischer, Shay Kyle, John Leung, Meredith Levy, Chris Liacouras, Denise Mack, Lisa Martin, Ellen Martin, Talaya McCright-Gill, Paul Menard-Katcher, Calies Menard-Katcher, Gabriela Mendoza, Melissa Mingler, Mike Minnicozzi, Amanda Muir, Vincent Mukkada, Cristin MurrayPetzold, Robert Newbury, Quan Nhu, Oghenekpaobor (Joel) Oyibo, Allisa Paliana, Zhaoxing Pan, Robbie Pesek, Kathryn Peterson, Heidi Poppendeck, Philip Putnam, Fabian Rivera, Marc Rothenberg, Amanda Rudman-Spergel, Kathleen Sable, Alain Schoepfer, Melissa Scott, Rachel Sheridan, Selma Sinanovic, Jonathan Spergel, MaryJo Strobel, Kiki Sun, Amy Tasco, Crystal Tholen, Katherine Thompson, Tiffany Tomkinson, Daisy Tran, Alexandra Tylicki, Tiina Urv, Mei-Lun Wang, Joshua Wechsler, Barry Wershil, Lisa Wheatley, Leah Wilkey, Guang-Yu Yang, Angelika Zalewski, Amy Zicarelli
Publikováno v:
J Allergy Clin Immunol
Recent advances in rare disease research are accelerated by the work of consortia that have been supported by the National Institutes of Health. Development of such consortia rely on multidisciplinary relationships and engagement with patient advocac
Autor:
Vincent A. Mukkada, Marc E. Rothenberg, J. Pablo Abonia, Pathre Purnima, Nives Zimmermann, Garrett A. Osswald, Kenneth M. Kaufman, Heather Foote, Philip E. Putnam, Michael D. Eby, Jeff E. Habel, Lisa J. Martin, Tetsuo Shoda, Kira Rehn, Wenying Zhang, Adina Y. Ballaban, Leah C. Kottyan, Margaret H. Collins, Netali Ben-Baruch Morgenstern, Julie M. Caldwell, Ting Wen
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Nature Communications
Nature Communications
Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease with a complex underlying genetic etiology. Herein, we conduct whole-exome sequencing of a multigeneration EoE pedigree (discovery set) and 61 additional multiplex families wit
Autor:
Marc E. Rothenberg, Shawna K.B. Hottinger, Nirmala Gonsalves, Glenn T. Furuta, Margaret H. Collins, Nicholas J. Talley, Kathryn Peterson, Calies Menard-Katcher, Macie Smith, Ikuo Hirano, Robert M. Genta, Mirna Chehade, Sandeep K. Gupta, Jonathan M. Spergel, Seema S. Aceves, Evan S. Dellon
Publikováno v:
J Allergy Clin Immunol
The US Food and Drug Administration hosted a workshop on July 21, 2021, to discuss the disease characteristics, natural history, and end points to assess treatment benefit in patients with eosinophilic gastrointestinal disorders (EGIDs) beyond eosino
Autor:
Amnah Yamani, Mark Rochman, Philip E. Putnam, Marc E. Rothenberg, Kavisha Arora, John A. Besse, Vincent A. Mukkada, Taeko K. Noah, Mirna Chehade, David Wu, Simone Vanoni, Julie M. Caldwell, Ting Wen, Chang Zeng, Simon P. Hogan, Margaret H. Collins, Lisa Waggoner, Justin C. Wheeler, Jazib Uddin, Anjaparavanda P. Naren
Publikováno v:
J Allergy Clin Immunol
Background Eosinophilic esophagitis (EoE) is characterized by histopathologic modifications of esophageal tissue, including eosinophil-rich inflammation, basal zone hyperplasia, and dilated intercellular spaces (DIS). The underlying molecular process
Autor:
Gisoo Ghaffari, Fouad J. Moawad, Amir F. Kagalwalla, Luc Biedermann, Constanza Ciriza de los Ríos, Carina Venter, Christopher Ma, Tim Vanuytsel, Elizabeth T. Jensen, Seema S. Aceves, Nirmala Gonsalves, Edoardo Savarino, Karen S. Hsu Blatman, Gary W. Falk, Mirna Chehade, Philip E. Putnam, Alex Straumann, Berber Vlieg-Boerstra, Vincent A. Mukkada, Robert D. Pesek, Carla M. Davis, Thomas Greuter, Amanda B. Muir, Ulrike von Arnim, Brian G. Feagan, Noam Zevit, Robert M. Genta, Tiffany H. Taft, Ekaterina Safroneeva, Rish K. Pai, Dagmar Simon, Jonathan M. Spergel, Philipp Schreiner, Calies Menard-Katcher, Helen M. Larsson, Evan S. Dellon, David A. Katzka, Marc E. Rothenberg, Sandeep K. Gupta, Antonella Cianferoni, Nicola de Bortoli, Marjorie M. Walker, Vipul Jairath, Margaret H. Collins, Frederic Clayton, Roberto Penagini, Jorge Amil Dias, Guang Yu Yang, Thomas C. Smyrk, Glenn T. Furuta, Dan Atkins, Ikuo Hirano, John Leung, John T. Woosley, Joanne C. Masterson, Alain M. Schoepfer, Joshua B. Wechsler, Philip Woodland, Albert J. Bredenoord, Alberto Ravelli, Doug Johnston, Ingrid Terreehorst, Kathryn A. Peterson, Hubert Louis, Carine Blanchard, Jeffrey A. Alexander, Mario C. Vieira, Paul Menard-Katcher, Michael Vieth, Russell J. Hopp, Nicoleta C. Arva, Christoph Schlag
Publikováno v:
Journal of allergy and clinical immunology. Mosby Inc.
Ma, Christopher; Schoepfer, Alain M; Dellon, Evan S; Bredenoord, Albert J; Chehade, Mirna; Collins, Margaret H; Feagan, Brian G; Furuta, Glenn T; Gupta, Sandeep K; Hirano, Ikuo; Jairath, Vipul; Katzka, David A; Pai, Rish K; Rothenberg, Marc E; Straumann, Alex; Aceves, Seema S; Alexander, Jeffrey A; Arva, Nicoleta C; Atkins, Dan; Biedermann, Luc; ... (2022). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS). Journal of allergy and clinical immunology, 149(2), pp. 659-670. Mosby 10.1016/j.jaci.2021.07.001
Ma, Christopher; Schoepfer, Alain M; Dellon, Evan S; Bredenoord, Albert J; Chehade, Mirna; Collins, Margaret H; Feagan, Brian G; Furuta, Glenn T; Gupta, Sandeep K; Hirano, Ikuo; Jairath, Vipul; Katzka, David A; Pai, Rish K; Rothenberg, Marc E; Straumann, Alex; Aceves, Seema S; Alexander, Jeffrey A; Arva, Nicoleta C; Atkins, Dan; Biedermann, Luc; ... (2022). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS). Journal of allergy and clinical immunology, 149(2), pp. 659-670. Mosby 10.1016/j.jaci.2021.07.001
BACKGROUND: End points used to determine treatment efficacy in eosinophilic esophagitis (EoE) have evolved over time. With multiple novel therapies in development for EoE, harmonization of outcomes measures will facilitate evidence synthesis and appr